| Toremifene |
EU/1/96/004/001 |
Fareston, Tablet, 60, mg, Pack: 30 |
Orion Corporation, Финландия |
Orion Corporation Orion Pharma - Финландия |
34.32 |
6.86 |
41.18 |
6% |
2.06 |
36.38 |
7.28 |
43.66 |
18% |
6.18 |
42.56 |
8.51 |
51.07 |
|
КЦ-1396/19.02.2010 |
19.03.2010 |
19.03.2010 |
Неактивен |
1217 |
| Medroxyprogesterone |
20000510 |
Farlutal, Tablet, 500, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
59.61 |
11.92 |
71.53 |
4% |
2.38 |
61.99 |
12.40 |
74.39 |
16% |
9.54 |
71.53 |
14.31 |
85.84 |
промяна на обстоятелства НСР-7326/29.10.2015 |
HCP-9327/16.05.2016 |
02.07.2016 |
02.07.2016 |
Заличен |
1644 |
| Medroxyprogesterone |
20000510 |
Farlutal, Tablet, 500, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
59.61 |
11.92 |
71.53 |
4% |
2.38 |
61.99 |
12.40 |
74.39 |
16% |
9.54 |
71.53 |
14.31 |
85.84 |
промяна на обстоятелства НСР-7326/29.10.2015 |
КЦ-3163/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
1644 |
| Medroxyprogesterone |
II-11874/18.11.2005 |
Farlutal, Tablet, 500, mg, Pack: 30 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Via del Commercio, Marino del Tronto, Ascoli Piceno, Italy |
93.16 |
18.63 |
111.79 |
4% |
3.73 |
96.89 |
19.38 |
116.27 |
16% |
14.91 |
111.80 |
22.36 |
134.16 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
1644 |
| Medroxyprogesterone |
20000511 |
Farlutal Depot, Suspension for injection, 500 mg/2.5 ml, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Италия |
4.17 |
0.83 |
5.00 |
7% |
0.29 |
4.46 |
0.89 |
5.35 |
20% |
0.83 |
5.29 |
1.06 |
6.35 |
промяна на обстоятелства НСР-7379/05.11.2015 ; Цената е вписана в регистъра на пределните цени с решение НСР-7380/05.11.2015 (в сила от 02.12.2015) |
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Заличен |
606 |
| Epirubicin |
20030657 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 25 ml, -, Pack: 1 |
Pfizer Europe MA EEIG, Белгия |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
44.10 |
8.82 |
52.92 |
4% |
1.76 |
45.86 |
9.17 |
55.03 |
16% |
7.06 |
52.92 |
10.58 |
63.50 |
Промяна на обстоятелства НСР-13614/25.08.2017; НСР-17422/06.12.2018 |
НСР-8331/26.02.2016 |
16.03.2016 |
02.01.2019 |
Активен |
2322 |
| Epirubicin |
20030657 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 25 ml, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
44.10 |
8.82 |
52.92 |
4% |
1.76 |
45.86 |
9.17 |
55.03 |
16% |
7.06 |
52.92 |
10.58 |
63.50 |
Промяна на обстоятелства НСР-13614/25.08.2017 |
НСР-8331/26.02.2016 |
16.03.2016 |
02.10.2017 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 25 ml, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
44.10 |
8.82 |
52.92 |
4% |
1.76 |
45.86 |
9.17 |
55.03 |
16% |
7.06 |
52.92 |
10.58 |
63.50 |
|
НСР-8331/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 5 ml, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.20 |
2.24 |
13.44 |
промяна на обстоятелства НСР-4565/03.09.2014 |
НСР-1815/25.11.2013; НСР-12089/21.03.2017 |
12.12.2013 |
02.05.2017 |
Заличен |
2321 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 2 mg/ml - 5 ml, -, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.20 |
2.24 |
13.44 |
промяна на обстоятелства НСР-4565/03.09.2014 |
НСР-1815/25.11.2013 |
12.12.2013 |
12.12.2013 |
Неактивен |
2321 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Actavis Italy S.p.A., Italy; Pfizer Service Company bvba, Белгия |
58.73 |
11.75 |
70.48 |
4% |
2.35 |
61.08 |
12.22 |
73.30 |
16% |
9.40 |
70.48 |
14.10 |
84.58 |
промяна на обстоятелства НСР-4565/03.09.2014 |
НСР-1815/25.11.2013 |
12.12.2013 |
12.12.2013 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
86.31 |
17.26 |
103.57 |
4% |
3.45 |
89.76 |
17.95 |
107.71 |
16% |
13.81 |
103.57 |
20.71 |
124.28 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
14.45 |
2.89 |
17.34 |
6% |
0.87 |
15.32 |
3.06 |
18.38 |
18% |
2.60 |
17.92 |
3.58 |
21.50 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2321 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
110.17 |
22.03 |
132.20 |
4% |
4.41 |
114.58 |
22.92 |
137.50 |
16% |
17.63 |
132.21 |
26.44 |
158.65 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2322 |
| Epirubicin |
II-4264/19.02.2009 |
Farmorubicin PFS, Solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
22.65 |
4.53 |
27.18 |
6% |
1.36 |
24.01 |
4.80 |
28.81 |
18% |
4.08 |
28.09 |
5.62 |
33.71 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2321 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
44.18 |
8.84 |
53.02 |
4% |
1.77 |
45.95 |
9.19 |
55.14 |
16% |
7.07 |
53.02 |
10.60 |
63.62 |
корекц. решение НСР-2590/24.01.2014; Цената е заличена с решение НСР-4567/03.09.2014( в сила от 18.09.2014) |
НСР-1816/25.11.2013 |
12.12.2013 |
12.12.2013 |
Заличен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
8.82 |
1.76 |
10.58 |
7% |
0.62 |
9.44 |
1.89 |
11.33 |
20% |
1.76 |
11.20 |
2.24 |
13.44 |
корекц. решение НСР-2590/24.01.2014; Цената е заличена с решение НСР-2808/17.02.2014 |
НСР-1816/25.11.2013 |
12.12.2013 |
12.12.2013 |
Заличен |
2319 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
44.20 |
8.84 |
53.04 |
4% |
1.77 |
45.97 |
9.19 |
55.16 |
16% |
7.07 |
53.04 |
10.61 |
63.65 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
13.28 |
2.66 |
15.94 |
6% |
0.80 |
14.08 |
2.82 |
16.90 |
18% |
2.39 |
16.47 |
3.29 |
19.76 |
|
КЦ-3193/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
2319 |
| Epirubicin |
II-9863/02.11.2004 |
Farmorubicin RD, Powder for solution for injection, 50, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
106.77 |
21.35 |
128.12 |
4% |
4.27 |
111.04 |
22.21 |
133.25 |
16% |
17.08 |
128.12 |
25.62 |
153.74 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2320 |
| Epirubicin |
II-9862/02.11.2004 |
Farmorubicin RD, Powder and solvent for solution for injection, 10, mg, Pack: 1 |
Pfizer Enterprises SARL, Люксембург |
Pfizer Italia S.r.l., Viale Pasteur 10, 20014, Nerviano (Milan), Italy |
16.31 |
3.26 |
19.57 |
6% |
0.98 |
17.29 |
3.46 |
20.75 |
18% |
2.94 |
20.23 |
4.05 |
24.28 |
|
КЦ-672/06.03.2009 |
23.03.2009 |
23.03.2009 |
Неактивен |
2319 |
| Benralizumab |
EU/1/17/1252/001 |
Fasenra, Solution for injection, 30, mg, Pack: 1 prefilled syringe |
Astra Zeneca AB, Швеция |
MedImmune UK Ltd, Великобритания; MedImmune Pharma B.V., Нидерландия |
4302.83 |
860.57 |
5163.40 |
4% |
10.00 |
4312.83 |
862.57 |
5175.40 |
16% |
25.00 |
4337.83 |
867.57 |
5205.40 |
|
НСР-17554/19.12.2018 предварително изпълнение |
19.12.2018 |
02.01.2019 |
Активен |
16370 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
Astra Zeneca AB, Швеция |
AstraZeneca UK Ltd, UK |
879.24 |
175.85 |
1055.09 |
4% |
10.00 |
889.24 |
177.85 |
1067.09 |
16% |
25.00 |
914.24 |
182.85 |
1097.09 |
корекц. Решение НСР-3464/16.05.2014; Промяна на обстоятелствата НСР-16286/27.07.2018; Корекционно решение НСР-17279/14.11.2018 |
НСР-3307/24.04.2014; НСР-14906/25.01.2018; НСР-17009/16.10.2018 (предварително изпълнение) |
16.10.2018 |
02.12.2018 |
Активен |
2765 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
Astra Zeneca AB, Швеция |
AstraZeneca UK Ltd, UK |
879.24 |
175.85 |
1055.09 |
4% |
10.00 |
889.24 |
177.85 |
1067.09 |
16% |
25.00 |
914.24 |
182.85 |
1097.09 |
корекц. Решение НСР-3464/16.05.2014; Промяна на обстоятелствата НСР-16286/27.07.2018. |
НСР-3307/24.04.2014; НСР-14906/25.01.2018; НСР-17009/16.10.2018 (предварително изпълнение) |
16.10.2018 |
02.11.2018 |
Неактивен |
2765 |
| Fulvestrant |
EU/1/03/269/002 |
Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles |
Astra Zeneca AB, Швеция |
AstraZeneca UK Ltd, UK |
886.62 |
177.32 |
1063.94 |
4% |
10.00 |
896.62 |
179.32 |
1075.94 |
16% |
25.00 |
921.62 |
184.32 |
1105.94 |
корекц. Решение НСР-3464/16.05.2014; Промяна на обстоятелствата НСР-16286/27.07.2018. |
НСР-3307/24.04.2014; НСР-14906/25.01.2018 |
09.02.2018 |
02.09.2018 |
Неактивен |
2765 |